Tehila BEN-MOSHE
12Patents
2h-index
21Co-inventors
50Inventor score
Filing activity: Mar 2, 2011 → Apr 8, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10081679B2 | Compositions comprising anti-CEACAM1 and anti-PD antibodies for cancer therapy | Chemistry; Metallurgy | 7 | Active |
| US9194011B2 | Stabilized alpha-galactosidase and uses thereof | Human Necessities | 6 | Active |
| US10280414B2 | Stabilized α-galactosidase and uses thereof | Human Necessities | 2 | Active |
| US11236162B2 | Antibodies against ILT2 | Chemistry; Metallurgy | 2 | Active |
| US10870842B2 | Stabilized alpha-galactosidase and uses thereof | Human Necessities | 1 | Active |
| US10550196B2 | Humanized antibodies against CEACAM1 | Physics | 1 | Active |
| US11866509B2 | Humanized antibodies against CEACAM1 | Physics | 1 | Active |
| US12071479B2 | Antibodies against ILT2 and use thereof | Chemistry; Metallurgy | 1 | Active |
| US12385026B2 | Stabilized alpha-galactosidase and uses thereof | Human Necessities | 0 | Active |
| US11427647B2 | Polynucleotides encoding humanized antibodies against CEACAM1 | Physics | 0 | Active |
| US12391755B2 | Methods of use for anti-ILT2 antibodies | Chemistry; Metallurgy | 0 | Active |
| US12139534B2 | Methods and compositions for decreasing soluble immune receptor CD28 | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.